This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Aurora Parodi, MD; Giampiero Rivara, MD; Marcella Guarrera, PharD
University of Genoa (Italy)

JAMA. 1992;268(1):51-52.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—A 59-year-old woman had been diagnosed as having subacute cutaneous lupus erythematosus (SCLE) 2 years previously and was given chloroquine and prednisone (250 mg/d), which cleared her skin lesions. In such a quiescent state, she began taking calcitonin and 250 to 500 mg per day of naproxen sodium. One month later, in spring, without any recreational or occupational sun exposure, typical SCLE lesions developed on her upper chest and forearms (Figure). The patient was given azathioprine (50 mg/d) and hydroxychloroquine sulfate (500 mg/d) without any benefit. Azathioprine was discontinued 15 days later and naproxen 1 month later. Only then did the SCLE lesions clear.

Results of routine laboratory tests were normal or negative, but her creatinine level was high (190 µmol/L; normal, <100 µmol/L), and creatinine clearance was low (0.44 mL/s; normal, 1.24 to 2.08 mL/s). Before naproxen treatment she had anti-SS-A/Ro antibodies at 1:4 titer that . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?